Coverage
Filings
Genmab A/S announced encouraging results from its Phase 1/2 RAINFOL-01 trial for rinatabart sesutecan (Rina-S), an investigational antibody-drug conjugate (ADC), in heavily pretreated patients with advanced endometrial cancer.
| 23 Mar 2012 |
| Genmab Provides Update on Ofatumumab Phase III Head to Head Study in DLBCL | 19 Mar 2012 |
| Genmab 2011 Annual Report | 7 Mar 2012 |
| Genmab Reaches Second Milestone in Lundbeck Collaboration | 10 Feb 2012 |
| Arzerra Fourth Quarter and Full Year 2011 Net Sales Figures | 7 Feb 2012 |